259 related articles for article (PubMed ID: 21949844)
1. 11β-Hydroxysteroid dehydrogenase-1 is a novel regulator of skin homeostasis and a candidate target for promoting tissue repair.
Terao M; Murota H; Kimura A; Kato A; Ishikawa A; Igawa K; Miyoshi E; Katayama I
PLoS One; 2011; 6(9):e25039. PubMed ID: 21949844
[TBL] [Abstract][Full Text] [Related]
2. 11β-hydroxysteroid dehydrogenase 1 specific inhibitor increased dermal collagen content and promotes fibroblast proliferation.
Terao M; Tani M; Itoi S; Yoshimura T; Hamasaki T; Murota H; Katayama I
PLoS One; 2014; 9(3):e93051. PubMed ID: 24667799
[TBL] [Abstract][Full Text] [Related]
3. Localization, age- and site-dependent expression, and regulation of 11β-hydroxysteroid dehydrogenase type 1 in skin.
Tiganescu A; Walker EA; Hardy RS; Mayes AE; Stewart PM
J Invest Dermatol; 2011 Jan; 131(1):30-6. PubMed ID: 20739946
[TBL] [Abstract][Full Text] [Related]
4. Topical 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Corrects Cutaneous Features of Systemic Glucocorticoid Excess in Female Mice.
Tiganescu A; Hupe M; Uchida Y; Mauro T; Elias PM; Holleran WM
Endocrinology; 2018 Jan; 159(1):547-556. PubMed ID: 29087473
[TBL] [Abstract][Full Text] [Related]
5. Expression profiles of cortisol-inactivating enzyme, 11β-hydroxysteroid dehydrogenase-2, in human epidermal tumors and its role in keratinocyte proliferation.
Terao M; Itoi S; Murota H; Katayama I
Exp Dermatol; 2013 Feb; 22(2):98-101. PubMed ID: 23362866
[TBL] [Abstract][Full Text] [Related]
6. 11β-Hydroxysteroid dehydrogenase 1 contributes to the pro-inflammatory response of keratinocytes.
Itoi S; Terao M; Murota H; Katayama I
Biochem Biophys Res Commun; 2013 Oct; 440(2):265-70. PubMed ID: 24055708
[TBL] [Abstract][Full Text] [Related]
7. 11β-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects.
Tiganescu A; Tahrani AA; Morgan SA; Otranto M; Desmoulière A; Abrahams L; Hassan-Smith Z; Walker EA; Rabbitt EH; Cooper MS; Amrein K; Lavery GG; Stewart PM
J Clin Invest; 2013 Jul; 123(7):3051-60. PubMed ID: 23722901
[TBL] [Abstract][Full Text] [Related]
8. Local cortisol/corticosterone activation in skin physiology and pathology.
Terao M; Katayama I
J Dermatol Sci; 2016 Oct; 84(1):11-16. PubMed ID: 27431412
[TBL] [Abstract][Full Text] [Related]
9. 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Attenuates the Adverse Effects of Glucocorticoids on Dermal Papilla Cells.
Lee SE; Lee EY; Kang SJ; Lee SH
Yonsei Med J; 2017 Nov; 58(6):1204-1210. PubMed ID: 29047245
[TBL] [Abstract][Full Text] [Related]
10. UVB induces epidermal 11β-hydroxysteroid dehydrogenase type 1 activity in vivo.
Tiganescu A; Hupe M; Jiang YJ; Celli A; Uchida Y; Mauro TM; Bikle DD; Elias PM; Holleran WM
Exp Dermatol; 2015 May; 24(5):370-6. PubMed ID: 25739654
[TBL] [Abstract][Full Text] [Related]
11. Local Glucocorticoid Activation by 11β-Hydroxysteroid Dehydrogenase 1 in Keratinocytes: The Role in Hapten-Induced Dermatitis.
Terao M; Itoi S; Matsumura S; Yang L; Murota H; Katayama I
Am J Pathol; 2016 Jun; 186(6):1499-510. PubMed ID: 27070821
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease.
Candia R; Riquelme A; Baudrand R; Carvajal CA; Morales M; Solís N; Pizarro M; Escalona A; Carrasco G; Boza C; Pérez G; Padilla O; Cerda J; Fardella CE; Arrese M
Liver Int; 2012 Mar; 32(3):392-9. PubMed ID: 22136330
[TBL] [Abstract][Full Text] [Related]
13. Novel 11β-hydroxysteroid dehydrogenase 1 inhibitors reduce cortisol levels in keratinocytes and improve dermal collagen content in human ex vivo skin after exposure to cortisone and UV.
Boudon SM; Vuorinen A; Geotti-Bianchini P; Wandeler E; Kratschmar DV; Heidl M; Campiche R; Jackson E; Odermatt A
PLoS One; 2017; 12(2):e0171079. PubMed ID: 28152550
[TBL] [Abstract][Full Text] [Related]
14. Role of corticosteroids in skin physiology and therapeutic potential of an 11β-HSD1 inhibitor: A review.
Hall L; Hart R
Int J Dermatol; 2024 Apr; 63(4):443-454. PubMed ID: 38146184
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of 11β-HSD1 Expression by Insulin in Skin: Impact for Diabetic Wound Healing.
Brazel CB; Simon JC; Tuckermann JP; Saalbach A
J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33260645
[TBL] [Abstract][Full Text] [Related]
16. Hyperglycemia-activated 11β-hydroxysteroid dehydrogenase type 1 increases endoplasmic reticulum stress and skin barrier dysfunction.
Lee YB; Hwang HJ; Kim E; Lim SH; Chung CH; Choi EH
Sci Rep; 2023 Jun; 13(1):9206. PubMed ID: 37280272
[TBL] [Abstract][Full Text] [Related]
17. Role of 11β-hydroxysteroid dehydrogenase type 1 in the development of atopic dermatitis.
Lee NR; Kim BJ; Lee CH; Lee YB; Lee S; Hwang HJ; Kim E; Kim SH; Lee MG; Lee SE; Lavery GG; Choi EH
Sci Rep; 2020 Nov; 10(1):20237. PubMed ID: 33214595
[TBL] [Abstract][Full Text] [Related]
18. Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial.
Ajjan RA; Hensor EMA; Del Galdo F; Shams K; Abbas A; Fairclough RJ; Webber L; Pegg L; Freeman A; Taylor AE; Arlt W; Morgan AW; Tahrani AA; Stewart PM; Russell DA; Tiganescu A
Eur J Endocrinol; 2022 Feb; 186(4):441-455. PubMed ID: 35113805
[TBL] [Abstract][Full Text] [Related]
19. 11beta-hydroxysteroid dehydrogenase type 1 is overexpressed in subcutaneous adipose tissue of morbidly obese patients.
Muñoz R; Carvajal C; Escalona A; Boza C; Pérez G; Ibáñez L; Fardella C
Obes Surg; 2009 Jun; 19(6):764-70. PubMed ID: 18592327
[TBL] [Abstract][Full Text] [Related]
20. Local cortisol activation is involved in EGF-induced immunosuppression.
Matsumura S; Terao M; Itami S; Katayama I
Dermatoendocrinol; 2017; 9(1):e1412018. PubMed ID: 29484105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
